Title: FDA Approves Wider Use of Plasma as Coronavirus Treatment
Category: Health News
Created: 8/24/2020 12:00:00 AM
Last Editorial Review: 8/25/2020 12:00:00 AM

NEW DELHI: An Indian pharmacist died and his boss was left hospitalised after the pair drank a chemical concoction they had developed in an effort to treat coronavirus, police said Saturday. The men worked for a herbal medicine company and were testing their treatment — a mix of nitric oxide...

NEW DELHI: An Indian pharmacist died and his boss was left hospitalised after the pair drank a chemical concoction they had developed in an effort to treat coronavirus, police said on Saturday.The men worked for a herbal medicine company and were testing their treatment -- a mix of nitric oxide...

K Sivanesan, 47, and his colleague Rajkumar worked for a herbal medicine company and tested their treatment - a mix of nitric oxide and sodium nitrate - at a home in southern Chennai city.

The Insurance Regulatory and Development Authority of India (IRDAI) has issued norms for general and health insurers for quick settlement of claims filed by policyholders for coronavirus (COVID-19) disease/infection.

A senior scientist at a government biomedical research laboratory has been thwarted in his efforts to conduct experiments on possible treatments for the new coronavirus because of the Trump administration’s restrictions on research with human fetal tissue. The scientist, Kim Hasenkrug, an immunologist at the National Institutes of Health’s Rocky Mountain Laboratories in Montana, has […]

With a vaccine probably at least a year away, antibody therapies have become, in the eyes of some experts, one of the most promising weapons against COVID-19. The work involving Winter the llama's antibodies shows promise.

The major U.S. index futures are currently pointing to a sharply higher opening on Friday, with stocks likely to add to the gains posted in the previous session.

Splicing damaged nerves, getting astronauts to Mars healthy and sane and smoke on glaciers

To fight the new coronavirus, researchers are investigating more than 60 drugs, including remdesivir and hydroxychloroquine and brand new ones. Here’s a breakdown of progress so far

To fight the new coronavirus, researchers are investigating more than 60 drugs, including remdesivir and hydroxychloroquine and brand new ones. Here’s a breakdown of progress so far

Donald Trump has told a coronavirus press conference that the idea of injecting Covid-19 patients with disinfectant "sounds interesting to me".

Disinfectants must never be injected, the company which makes Dettol has stressed, after Donald Trump mused on its potential as a treatment for coronavirus.

The United States has authorised the emergency use of the Ebola drug remdesivir for treating coronavirus, clearing the way for the potential treatment of 140,000 patients around the country.

TV host said she was grateful for NHS workers doing 'so much' to help husband Derek Draper

Trials to treat COVID-19 using the blood plasma from those who have already recovered from the illness have begun.

Hospitals in London and Birmingham have been supplied with fourteen units of convalescent plasma to see if it helps people who are battling

The Australian share market ends higher, despite Wall Street giving up most of its gains after leaked test results of a potential COVID-19 treatment prove disappointing.

The search for existing drugs that may help treat coronavirus infections now has researchers testing the heartburn drug Pepcid, among others.

Investors shrug off US growth gloom after promising data from remdesivir drug trial

• Coronavirus – latest updates
• See all our coronavirus coverage

Shares have soared on the world’s stock markets after investors shrugged off a deep slump in the US economy and pinned their hopes on a possible breakthrough in treatment for Covid-19.

Despite news that the longest expansion in US history came to an abrupt end in the first three months of 2020, financial markets were buoyed by an update from the American biopharma company Gilead Sciences on its experimental drug remdesivir.

Researchers in America have been studying famotidine, the active ingredient in Pepcid, as a potential treatment for COVID-19.

Kare Schultz, CEO of Teva Pharmaceuticals, joins "Squawk on the Street" to discuss the coronavirus pandemic and potential treatments.

Remdesivir news moves markets more than economic data or Fed action

Scientists behind the cloning of Dolly the Sheep in Edinburgh, 1996 (pictured) say the new treatment could be available for the NHS to treat the coronavirus by July.

Hello,Welcome to Dispensed, Business Insider's weekly healthcare newsletter. Are you all ready for the Polar Vortex? I sure am (if only to keep my seasonal allergies at bay for a quick minute). Here's hoping it makes social distancing a bit easier here in Brooklyn.I made a run by Prospect Park yesterday, and it was bustling with walkers, bikers, and joggers. The ice cream trucks are out, making me wonder whether that's a safe interaction I can look forward to this summer. It's nice to hear that my neighbors won't be leaving any time soon — as Jeremy Berke reports, Gov. Andrew Cuomo has frozen evictions for New Yorkers until August 20. Are you new to the newsletter? You can sign up here. 75635152The search for remdesivir has proven frustrating for hospitalsThe race to develop treatments and

Bernie Sanders called out the Trump administration for its 'incompetence and recklessness' as he demanded Thursday that the president declare the coronavirus outbreak a national emergency.

Donald Trump announced the government will pay for coronavirus treatments for those without insurance by using funds from the $2.2 trillion economic aid package the president signed into law last week. 

The President had offered Boris Johnson support after hearing he had been taken to intensive care in London due to coronavirus symptoms. The PM is understood to remain in 'good spirits'.

Major retailers such as Amazon and Walgreens appeared to be experiencing shortages of the medication.

Wall Street stocks opened higher amid reaction to developments regarding the use of Gilead Sciences' antiviral drug remdesivir as a potential new treatment for Covid-19 patients. Gilead Sciences said on Wednesday that preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a five-day dosage of remdesivir improved and more than half were discharged from the hospital within two weeks. Later Wednesday, White House health advisor Dr. Anthony Fauci said NIAID's remdesivir drug trial, which enrolled about 800 patients, showed quite good news and that the drug would set a new standard of care for Covid-19 patients.

Investor sentiment around the world was brightened by Gilead Sciences Inc.'s announcement that preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a five-day dosage of remdesivir improved and more than half were discharged from the hospital within two weeks. Later Wednesday, White House health advisor Dr. Anthony Fauci said NIAID's remdesivir drug trial, which enrolled about 800 patients, showed quite good news and that the drug would set a new standard of care for Covid-19 patients. Globally, the coronavirus pandemic has infected more than 3.1 million and taken at least 226,771 lives, according to data compiled by John Hopkins University.

Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1,400 patients treated at Columbia University in New York, researchers reported Thursday in the New England Journal of Medicine.

A pharmacist died and his boss was left hospitalised after the pair drank a chemical concoction they had developed in an effort to treat coronavirus, police said Saturday. The men worked for a herbal...

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine